scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1028526240 |
P356 | DOI | 10.1007/S12013-014-0438-Y |
P8608 | Fatcat ID | release_zibw2pa5u5dznbcbnxnnbqde6u |
P698 | PubMed publication ID | 25510462 |
P2093 | author name string | Jianxin Cheng | |
Wei Shen | |||
Jie Yin | |||
Xiurong Li | |||
Bingfeng Liang | |||
P2860 | cites work | Noscapine induces apoptosis in human glioma cells by an apoptosis-inducing factor-dependent pathway | Q39975147 |
An IAP-IAP complex inhibits apoptosis | Q40541576 | ||
Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer | Q40673230 | ||
Noscapine inhibits tumor growth with little toxicity to normal tissues or inhibition of immune responses | Q40861714 | ||
p53 and p21 determine the sensitivity of noscapine-induced apoptosis in colon cancer cells | Q42576880 | ||
Minor alteration of microtubule dynamics causes loss of tension across kinetochore pairs and activates the spindle checkpoint | Q43895739 | ||
Antitumor activity of noscapine in human non-small cell lung cancer xenograft model | Q46704388 | ||
Expression of signaling molecules associated with apoptosis in human ischemic stroke tissue | Q48219003 | ||
The "multi" of drug resistance explained by oscillating drug transporters, drug-membrane physical interactions and spatial dimensionality. | Q51601160 | ||
COX-2 is expressed in human pulmonary, colonic, and mammary tumors. | Q53402915 | ||
Selection of optimal antisense accessible sites of survivin and its application in treatment of gastric cancer | Q31142003 | ||
Isolation and functional characterization of single domain antibody modulators of Caspase-3 and apoptosis | Q33343611 | ||
Noscapine, a benzylisoquinoline alkaloid, sensitizes leukemic cells to chemotherapeutic agents and cytokines by modulating the NF-kappaB signaling pathway | Q33794066 | ||
Apoptosis in cancer | Q33846227 | ||
Antitumor activity of Noscapine in combination with Doxorubicin in triple negative breast cancer | Q33851448 | ||
Targeting XIAP for the treatment of malignancy | Q33991803 | ||
Cell death inhibition: keeping caspases in check | Q34210024 | ||
A systematic overview of chemotherapy effects in ovarian cancer | Q34301239 | ||
Estimating the world cancer burden: Globocan 2000. | Q34518922 | ||
Part I: chemotherapy for epithelial ovarian cancer-treatment at first diagnosis | Q34826546 | ||
Biomolecular targets for platinum antitumor drugs | Q34948778 | ||
Anticancer activity of Noscapine, an opioid alkaloid in combination with Cisplatin in human non-small cell lung cancer | Q34982543 | ||
The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by Phenoxodiol is associated with Carboplatin sensitization | Q35632517 | ||
Opium alkaloid noscapine is an antitumor agent that arrests metaphase and induces apoptosis in dividing cells | Q35875879 | ||
An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy | Q36384930 | ||
Multidrug resistance: retrospect and prospects in anti-cancer drug treatment. | Q36536479 | ||
The anti-cancer activity of noscapine: a review. | Q37370653 | ||
X-linked Inhibitor of Apoptosis: A Chemoresistance Factor or a Hollow Promise | Q37777537 | ||
Targeting IAP proteins for therapeutic intervention in cancer | Q37980321 | ||
Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-kappaB activation through inhibition of IkappaBalpha kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1. | Q38353590 | ||
Paclitaxel-resistant human ovarian cancer cells undergo c-Jun NH2-terminal kinase-mediated apoptosis in response to noscapine | Q38363629 | ||
Celastrol inhibits breast cancer cell invasion via suppression of NF-ĸB-mediated matrix metalloproteinase-9 expression | Q39484899 | ||
Let-7a microRNA suppresses therapeutics-induced cancer cell death by targeting caspase-3. | Q39945284 | ||
P433 | issue | 1 | |
P921 | main subject | apoptotic process | Q14599311 |
ovarian cancer | Q172341 | ||
cisplatin | Q412415 | ||
cancer cell line | Q23058136 | ||
P304 | page(s) | 203-213 | |
P577 | publication date | 2014-12-16 | |
P1433 | published in | Cell Biochemistry and Biophysics | Q15755135 |
P1476 | title | Noscapine Increases the Sensitivity of Drug-Resistant Ovarian Cancer Cell Line SKOV3/DDP to Cisplatin by Regulating Cell Cycle and Activating Apoptotic Pathways | |
P478 | volume | 72 |
Q57804591 | Bitter taste receptors are expressed in human epithelial ovarian and prostate cancers cells and noscapine stimulation impacts cell survival |
Q60302272 | DEBIO 1143, an IAP inhibitor, reverses carboplatin resistance in ovarian cancer cells and triggers apoptotic or necroptotic cell death |
Q92689975 | LncRNA ANRIL affects the sensitivity of ovarian cancer to cisplatin via regulation of let-7a/HMGA2 axis |
Q92567882 | Overexpression of microRNA-195-5p reduces cisplatin resistance and angiogenesis in ovarian cancer by inhibiting the PSAT1-dependent GSK3β/β-catenin signaling pathway |
Q37015742 | Proteasome Inhibitor YSY01A Enhances Cisplatin Cytotoxicity in Cisplatin-Resistant Human Ovarian Cancer Cells |
Q47311101 | Reversal of drug-resistance by noscapine chemo-sensitization in docetaxel resistant triple negative breast cancer |
Q26801133 | The Noscapine Chronicle: A Pharmaco-Historic Biography of the Opiate Alkaloid Family and its Clinical Applications |
Q55346269 | The action mechanism of lncRNA-HOTAIR on the drug resistance of non-small cell lung cancer by regulating Wnt signaling pathway. |
Search more.